News

Feliza Mirasol is the science editor for 

Articles

Evonik's plant-based squalene, PhytoSquene, used in parenteral drug delivery applications, won the CPHI Excellence in Pharma Award in the “Sustainability” category. 

CPHI Award Granted to Evonik for Plant-based Adjuvant Used in Parenteral Drug Delivery

Patrick Lavery is an Editor for the MJH Life Sciences brands Pharmaceutical Technology and BioPharm International, and their respective websites, 

. He previously spent nearly a decade as a news anchor, reporter, and producer at New Jersey 101.5 FM.

Thermo Fisher Scientific's launch of its Accelerator Drug Development follows expansions of sites in Cincinnati, Ohio, and Bend, Ore., earlier in 2024 to enable R&D, manufacturing, and testing.

Thermo Fisher Introduces New CDMO and CRO Services at CPHI Milan 2024

The annual survey predicts that four of the five biggest biologics capacity holders in 2028 will comprise CMOs, which will control 45% of all CMO capacity in Asia.

CPHI Annual Survey Suggests 54% of Biologics Capacity in 2028 to be Held by CMOs and Hybrid Companies

Cellevate's nanofiber microcarriers are the first on the market for use in  manufacturing viral vectors used in gene therapy production, according to the company.

Cellevate to Pre-Launch Nanofiber Microcarriers for Viral Vector Production at CPHI Milan

SGD Pharma plans to showcase its siliconized molded glass vials at CPHI Milan as part of its range of sustainable products and services.

SGD Pharma to Showcase Sustainable Packaging with Siliconized Molded Glass Vials at CPHI Milan

The two companies are partnering to provide logistics and manufacturing services to biotechnology and pharma companies.

SK pharmteco and Cryoport Collaborate on Cell and Gene Therapies

Under the long-term supply agreement, Lonza will manufacture CASGEVY (exagamglogene autotemcel) for Vertex at its facility in Geleen, the Netherlands, and plans to expand manufacturing to Portsmouth, NH, in the United States.

Lonza to Manufacture Commercial Supply of Vertex’s Sickle Cell Disease Gene-Edited Cell Therapy, CASGEVY

Chris Spivey is the editorial director of 

Videos

Ecolab's Hayley Crowe, executive vice-president and general manager Global Life Sciences sat down at BIO 2024 to discuss technology innovations and how they have enhanced downstream bioprocessing.

A Look Into Bioprocessing Innovations for Downstream Processing Efficiencies (BIO 2024)

Novo Nordisk will use Korro Bio’s OPERA platform to develop RNA editing candidates for two targets to treat cardiometabolic diseases.


Novo Nordisk and Korro Bio Collaborate on Cardiometabolic Treatments

The new Vivaflow SU tangential flow filtration cassette is designed to be more flexible and user-friendly and offers enhanced ultrafiltration and diafiltration efficiency. 

Supplier News